Remote Pregnancy Monitoring to Improve Access

Remote Pregnancy Monitoring to Improve Access: The REACTIVE Trial

The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.

Inclusion Criteria:

• Singleton pregnancy
• Gestational age between 30 weeks 0 days and 35 weeks 6 days
• Pregnant patients who have clinical indication for fetal surveillance with NSTs (based on UPHS Health System clinical guidelines for antenatal monitoring)
• Able to provide written consent
• English speaking

Exclusion Criteria:

• Multiple gestations
• Maternal pre-gravid BMI greater than 45kg/m2
• Presence of an implanted pacemaker or defibrillator
• Active abdominal skin infection
• A known amniotic fluid index (AFI) less than 5cm or greater than 25cm on the most recent ultrasound (if available) prior to randomization
• Delivery is planned within 2 weeks of potential randomization